Inventor
LANMAN BRIAN ALAN
US30 patents
⚠️ This page may combine multiple inventors who share the name “LANMAN BRIAN ALAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AMGEN INC
28 patentsUS10640504B2May 5, 2020
Inhibitors of KRAS G12C and methods of using the same
AMGEN INC50 citations97
US10532042B2Jan 14, 2020
KRAS G12C inhibitors and methods of using the same
AMGEN INC49 citations97
US10519146B2Dec 31, 2019
KRAS G12C inhibitors and methods of using the same
AMGEN INC81 citations97
US11306087B2Apr 19, 2022
Inhibitors of KRAS G12C and methods of using the same
AMGEN INC16 citations94
US11096939B2Aug 24, 2021
KRAS G12C inhibitors and methods of using the same
AMGEN INC24 citations94
US11090304B2Aug 17, 2021
KRAS G12C inhibitors and methods of using the same
AMGEN INC33 citations94
US11045484B2Jun 29, 2021
KRAS G12C inhibitors and methods of using the same
AMGEN INC24 citations94
US11285135B2Mar 29, 2022
KRAS G12C inhibitors and methods of using the same
AMGEN INC20 citations93
US10988485B2Apr 27, 2021
KRAS G12C inhibitors and methods of using the same
AMGEN INC27 citations92
US11053226B2Jul 6, 2021
KRAS G12C inhibitors and methods of using the same
AMGEN INC25 citations91
US12083121B2Sep 10, 2024
Substituted piperazines as KRAS G12C inhibitors
AMGEN INC7 citations85
US11993597B2May 28, 2024
Inhibitors of KRAS G12C and methods of using the same
AMGEN INC8 citations85
US11905281B2Feb 20, 2024
KRAS G12C inhibitors and methods of using the same
AMGEN INC13 citations85
US11766436B2Sep 26, 2023
KRAS G12C inhibitors and methods of using the same
AMGEN INC11 citations85
US11285156B2Mar 29, 2022
Substituted piperazines as KRAS G12C inhibitors
AMGEN INC16 citations85
US10632128B2Apr 28, 2020
Compounds that inhibit Mcl-1 protein
AMGEN INC5 citations83
US8772480B2Jul 8, 2014
Inhibitors of PI3 kinase and/or mTOR
AMGEN INC5 citations71
US12440491B2Oct 14, 2025
KRAS G12C inhibitors and methods of using the same
AMGEN INC1 citations64
US12583854B2Mar 24, 2026
KRAS G12C inhibitors and methods of using the same
AMGEN INC0 citations62
US11807693B2Nov 7, 2023
Apelin polypeptides
AMGEN INC0 citations62
US7842685B2Nov 30, 2010
S1P1 receptor agonists and use thereof
AMGEN INC3 citations62
US11224601B1Jan 18, 2022
Compounds that inhibits MCL-1 protein
AMGEN INC0 citations61
US10941182B2Mar 9, 2021
Apelin polypeptides
AMGEN INC0 citations61
US11845760B2Dec 19, 2023
PRMT5 inhibitors
AMGEN INC1 citations56
US11364248B2Jun 21, 2022
Compounds that inhibit Mcl-1 protein
AMGEN INC0 citations52
US11279712B2Mar 22, 2022
Macrocyclic compounds that inhibit MCL-1 protein
AMGEN INC0 citations51
US10821115B2Nov 3, 2020
Compounds that inhibit Mcl-1 protein
AMGEN INC0 citations51
US12570672B2Mar 10, 2026
Macrocyclic compounds and methods of use
AMGEN INC0 citations41